Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single‐center, retrospective, propensity‐matched study

BACKGROUND: High rates of postoperative tumor recurrence contribute to poor outcome in hepatocellular carcinoma (HCC). Here, we investigated whether circulating tumor cells (CTCs) status can predict the benefit of adjuvant transcatheter arterial chemoembolization (TACE) in patients with HCC. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peng‐Xiang, Sun, Yun‐Fan, Zhou, Kai‐Qian, Cheng, Jian‐Wen, Hu, Bo, Guo, Wei, Yin, Yue, Huang, Jun‐Feng, Zhou, Jian, Fan, Jia, Cheung, Tan To, Qu, Xu‐Dong, Yang, Xin‐Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418815/
https://www.ncbi.nlm.nih.gov/pubmed/32702202
http://dx.doi.org/10.1002/ctm2.137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418815/
https://www.ncbi.nlm.nih.gov/pubmed/32702202
http://dx.doi.org/10.1002/ctm2.137

Ejemplares similares